These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28989042)
1. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug. Zhong S; Wu B; Dong X; Han Y; Jiang S; Zhang Y; Bai Y; Luo SX; Chen Y; Zhang H; Zhao G World Neurosurg; 2018 Jan; 109():e329-e342. PubMed ID: 28989042 [TBL] [Abstract][Full Text] [Related]
2. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
4. Identification of Driver Genes and Key Pathways of Pediatric Brain Tumors and Comparison of Molecular Pathogenesis Based on Pathologic Types. Zhong S; Wu B; Han Y; Cao Y; Yang L; Luo SX; Chen Y; Zhang H; Zhao G World Neurosurg; 2017 Nov; 107():990-1000. PubMed ID: 28751139 [TBL] [Abstract][Full Text] [Related]
5. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. Zeng J; Hua S; Liu J; Mungur R; He Y; Feng J Front Genet; 2022; 13():928407. PubMed ID: 36238156 [No Abstract] [Full Text] [Related]
6. Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin. Zhong S; Wu B; Wang X; Sun D; Liu D; Jiang S; Ge J; Zhang Y; Liu X; Zhou X; Jin R; Chen Y Mol Med Rep; 2019 Sep; 20(3):2712-2724. PubMed ID: 31322266 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
8. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. Xu P; Zhang G; Hou S; Sha LG Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215 [TBL] [Abstract][Full Text] [Related]
9. Computational analysis and verification of molecular genetic targets for glioblastoma. Xue L; Liu H; Chen Y; Wei L; Hong J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390 [TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
11. Aurora kinase A as a rational target for therapy in glioblastoma. Barton VN; Foreman NK; Donson AM; Birks DK; Handler MH; Vibhakar R J Neurosurg Pediatr; 2010 Jul; 6(1):98-105. PubMed ID: 20593995 [TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value. Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182 [TBL] [Abstract][Full Text] [Related]
13. Screening prognosis-related genes in glioblastoma by microarray analysis. Wang H; Zhang Y; Zhang C; Tong X Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312 [TBL] [Abstract][Full Text] [Related]
14. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression. Zhang X; Pan Y; Fu H; Zhang J Med Sci Monit; 2018 Nov; 24():8553-8564. PubMed ID: 30476929 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549 [TBL] [Abstract][Full Text] [Related]
16. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma. Dong C; Fan W; Fang S J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063 [TBL] [Abstract][Full Text] [Related]
17. Selected by gene co-expression network and molecular docking analyses, ENMD-2076 is highly effective in glioblastoma-bearing rats. Zhong S; Bai Y; Wu B; Ge J; Jiang S; Li W; Wang X; Ren J; Xu H; Chen Y; Zhao G Aging (Albany NY); 2019 Nov; 11(21):9738-9766. PubMed ID: 31706255 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
19. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA. Qiao W; Guo B; Zhou H; Xu W; Chen Y; Liang Y; Dong B Biochem Biophys Res Commun; 2017 Apr; 486(1):43-48. PubMed ID: 28242198 [TBL] [Abstract][Full Text] [Related]
20. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]